科创板受理企业145家 27家受理企业研发投入超亿元

  • 日期:07-16
  • 点击:(1245)

银河娱乐app

The science and technology board is gradually getting closer, and the first batch of 25 companies will be listed on July 22. From now on, Data Bao will interpret the science and technology acceptance enterprises from various dimensions and present them in the form of rankings. R&D investment is one of the most concerned focuses of the company, and the science and technology board series will be the first one with R&D investment.

The total research and development expenses of 145 accepted enterprises in 2018 totaled 11.854 billion yuan, accounting for 6.39% of the total operating income of the year. The total amount of R&D expenses of the two newly accepted enterprises reached 0.88 billion yuan, accounting for 10.97% of the operating income.

27 companies have received more than 100 million yuan in research and development investment

On the evening of July 9, the Shanghai Stock Exchange of the Shanghai Stock Exchange added two new companies, namely, Zhonglian Data and Chengdu Pioneer, and the number of cumulative acceptance enterprises increased to 145 (excluding the papaya movement that terminated the listing review). From the perspective of R&D investment, the annual R&D expenses of 27 enterprises in 2018 exceeded 100 million yuan.

China Tonghao ranked first with R&D expenses of 1.324 billion yuan, an increase of 12.24% over the previous period. Followed by the sound holdings, Biotech, 2018 annual research and development costs of 712 million yuan, 542 million yuan. In addition, 7 companies including China Resources Microelectronics, Jinshan Office, and Shipchip have exceeded 200 million yuan. It is worth mentioning that the first batch of 25 listed companies listed in the 2018 annual R&D expenses totaled 3.098 billion yuan, accounting for 26.13% of the total R&D expenses of all enterprises.

Among the 27 enterprises with R&D expenditures exceeding 100 million yuan, 7 are listed among the first listed companies, including the top Chinese number, the 9th in the rise, and the 15th and 16th in the ArcSoft. And Huaxing Chuangyuan and so on. In addition, among the first batch of listed companies, Xinguang Optoelectronics' 2018 annual R&D expenses are relatively low, only RMB 12 million. Rui Chuang Wei Na and China Micro are doubling the R&D expenses of the previous period.

RVnJJZUBg98c8w

The two industries have invested more than 15% in research and development in the past two years

xx据数据统计,2018年度145家企业的研发总费用为118.54亿元,占当年营业总收入的6.39%,而创业板市场的对应价值不到3在同一时期%。研发费用/营业收入)远远超过创业板。

在行业方面,行业认可企业中五个行业的研发费用总额超过10亿元。计算机,通信等电子设备制造业的研发成本最高,达到36.65亿元,比去年同期小幅增长1.21%。研发投资的第二,第三和第四名是软件和信息技术服务,制药和特种设备制造。 2018年研发费用总额超过15亿元。医药制造业和软件及信息技术服务业的研发费用较上期大幅增加,分别为5.5%和4.39%。

从研发投入来看,有两个行业,20%的研发投入超过15%,软件和信息技术服务行业达到18。01%,2017年行业的研发投入高达17.62%。此外,在过去两年中,制药和制药行业在研发方面的投入超过15%。在过去两年中,电气机械及设备制造业的研发投入并未超过2%。

RVnJJZq3VKahnu

11家公司连续三年在研发方面的投入超过20%

从单一公司的研发投入来看,58家公司的年度研发投入超过10%,占全部企业的40%。

其中,泽益药业是一家创新驱动的新药研发公司,专业从事肿瘤,出血,血液病,肝胆疾病等多个治疗领域,2018年研发投入1.37亿元。但是,该公司一直处于“燃烧阶段”。其2018年的收入仅为0.01亿元,其研发投入超过100倍。

其次是新接受的成都试点,其研发投入达到40.91%。此外,金山办事处,Microcore等六家公司已投入超过25%的研发资金。

从首批25家上市公司的角度来看,ArcSoft以研发投资的32.43%排名第一,其次是安吉科技,其2018年的研发投入达到21.64%。此外,瑞创威纳,乐信科技,齐齐科技等五家上市公司的研发投入超过15%。

需要时间延长,145家公司中有11家连续三年投资超过20%。包括ArcSoft技术上市,安吉科技,以及接受企业金山办事处,Hillstone网络,安恒信息等,除了新接受的成都飞行员的研发投入超过20%,超过20%。

RVnJJaCHQiYeQ

本文来自数据宝藏

欲了解更多精彩信息,请访问金融网站(www.jrj.com.cn)